These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4693613)

  • 1. Studies in multiple myeloma. I. Characteristics by immunoglobulin class.
    Murphy WM; Deodhar SD
    Cleve Clin Q; 1973; 40(1):1-7. PubMed ID: 4693613
    [No Abstract]   [Full Text] [Related]  

  • 2. Gel filtration analysis of multiple myeloma sera.
    Tóth I; Sellei C; Eckhardt S; Hindy I
    Haematologia (Budap); 1973; 7(1):7-16. PubMed ID: 4737470
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
    Fine JM; Rivat C; Lambin P; Ropartz C
    Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulin disturbances and their clinical significance.
    Solomon A; McLaughlin CL
    Med Clin North Am; 1973 Mar; 57(2):499-516. PubMed ID: 4632920
    [No Abstract]   [Full Text] [Related]  

  • 5. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.
    Isobe T; Osserman EF
    N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on human secretory immunoglobulin A. 3. J chain.
    Mestecky J; Zikan J; Butler WT; Kulhavy R
    Immunochemistry; 1972 Sep; 9(9):883-90. PubMed ID: 5073880
    [No Abstract]   [Full Text] [Related]  

  • 8. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
    Conway BP
    Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
    [No Abstract]   [Full Text] [Related]  

  • 9. IgD myeloma L-type. Immunochemical study of the first Brazilian case.
    Ferri RG; Llach HF; Balthazar P; Cobra CJ; de Souza Júnior JA
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):229-32. PubMed ID: 5006006
    [No Abstract]   [Full Text] [Related]  

  • 10. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anatomo-morphological characteristics of different protein types in myelomas (IgG, IgA and Bence Jones)].
    Voĭno-Iasenetskaia OV
    Probl Gematol Pereliv Krovi; 1974 Aug; 19(8):34-6. PubMed ID: 4408561
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver disease in multiple myeloma.
    Thomas FB; Clausen KP; Greenberger NJ
    Arch Intern Med; 1973 Aug; 132(2):195-202. PubMed ID: 4719547
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytology of myeloma cells.
    Hayhoe FG; Neuman Z
    J Clin Pathol; 1976 Oct; 29(10):916-22. PubMed ID: 824323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma with double M-proteins of IgD-lambda and IgA-kappa].
    Maruyama Y; Tanikawa S; Sakamaki H; Yahara Y; Onozawa Y; Hayashi Y; Kawaguchi K; Koike M; Ozawa N; Shimizu M
    Rinsho Ketsueki; 1987 Aug; 28(8):1475-80. PubMed ID: 3430755
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in multiple myeloma. II. Light chains.
    Murphy WM; Deodhar SD
    Cleve Clin Q; 1973; 40(1):9-14. PubMed ID: 4693618
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute phase reactants and clinical stages in multiple myeloma.
    San Miguel J; Vicente V; Battle J; Hernandez F; Lopez Borrasca A
    Neoplasma; 1981; 28(3):333-8. PubMed ID: 7290260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavior of immunoglobulin in monoclonal gammopathies and their classification and pathogenesis.
    Kano T
    Tohoku J Exp Med; 1970 Dec; 102(4):369-401. PubMed ID: 4102668
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma without paraprotein.
    Szücs J
    Haematologia (Budap); 1970; 4(1):97-102. PubMed ID: 5522360
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating appearance of IgD and IgG myeloma protein during treatment.
    Oxelius VA
    Scand J Haematol; 1971; 8(6):439-45. PubMed ID: 5160304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.